ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 141 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,920,790 | -13.7% | 308,313 | -7.2% | 0.10% | -23.3% |
Q3 2022 | $2,225,000 | +64.9% | 332,123 | +56.6% | 0.13% | +65.4% |
Q2 2022 | $1,349,000 | -36.9% | 212,123 | +514.8% | 0.08% | -92.9% |
Q2 2015 | $2,139,000 | +15.5% | 34,500 | +72.5% | 1.10% | +14.5% |
Q1 2015 | $1,852,000 | +489.8% | 20,000 | +157.7% | 0.96% | +724.1% |
Q4 2014 | $314,000 | – | 7,760 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |